Otonomy (OTIC) PT Lowered to $5 at Oppenheimer as Otividex Disappoints
Tweet
Share
E-mailGet Alerts OTIC Hot Sheet
Price: $2.32 +6.91%
Rating Summary:
8 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 31
Rating Summary:
8 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 8 | New: 31
Trade Now!
Join SI Premium – FREE
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Oppenheimer analyst Francois Brisebois lowered the price target on Otonomy (NASDAQ: OTIC) to $5.00 (from $12.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Assumes Otonomy (OTIC) at Overweight, PT Raised to $6
- MediaTek Inc. (2454:TT) (MDTKF) PT Raised to NT$1,250 at Credit Suisse
- Macquarie Downgrades Alchip Technologies Ltd (3661:TT) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
